Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 17 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 10808010

    Peptide inhibitors of phosphoglycerate mutase and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  2. US 10799584

    Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  3. US 10799580

    Expression vector delivery system and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  4. US 10787419

    Cannabinoid receptor mediating iminopyrazole compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

  5. US 10772897

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  6. US 10772849

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  7. US 10765694

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  8. US 10758613

    Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  9. US 10758614

    Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  10. US 10759838

    Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  11. US 10758526

    Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  12. US 10744193

    Immunogenic RSV polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  13. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  14. US 10738116

    Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  15. US 10738313

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  16. US 10737995

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  17. US 10738312

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  18. US 10730941

    Antigen-binding proteins targeting CD56 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  19. US 10723787

    Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  20. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  21. US 10716809

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  22. US 10709790

    Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  23. US 10711068

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  24. US 10703816

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.